Skip to main content
Log in

Faster uptake of biosimilars could save NHS money

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Hawkes N. Biosimilar versions of anti-TNF drugs could save NHS money, drug company claims. BMJ 2015: h5337, No. 351, 6 Oct 2015. Available from: URL: http://dx.doi.org/10.1136/bmj.h5337

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Faster uptake of biosimilars could save NHS money. PharmacoEcon Outcomes News 738, 3 (2015). https://doi.org/10.1007/s40274-015-2485-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2485-z

Navigation